Here are four notes:
1. The analysts have a 12-month price target of $22.44 on Surgery Partner shares.
2. Zacks recently upgraded company shares form a “sell” to a “buy” rating.
3. On Oct. 11, Surgery Partners shares plummeted 1.11 percent, trading at $19.98 per share.
4. The company has a 50-day moving average of $19.33 and 200-day moving average of $16.69.
More articles on surgery centers:
Jefferies analysts weigh in on SCA shares: 3 notes
Surgical Care Affiliates to refinance term loan facility and obtain incremental term loan: 4 thoughts
3 recent ASC acquisitions — October 6, 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
